retrovirology.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Retrovirology
official impact factor 6.47
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Retrovirology

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter Support

Explore Retrovirology

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles RSS
  • Most viewed RSS
  • Archive
  • Supplements
  • Article collections

Retrovirology publishes selected collections of research articles, conference proceedings, reviews and reports as supplements, which are free to access online. All articles published in supplements are subject to peer review; meeting abstracts undergo review and selection by the conference. Find out more about publishing a supplement with BioMed Central.

Volume 6 Supplement 3

AIDS Vaccine 2009

Meeting abstracts

AIDS Vaccine 2009

Paris, France

19-22 October 2009

Edited by Anna Laura Ross

Conference website

Oral presentation   Open Access

S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers

SA Freel, PK Chattopadhyay, L Lamoreaux, D Zarkowsky, RG Overman, C Ochsenbauer-Jambor, JC Kappes, CK Cunningham, TN Denny, KJ Weinhold, G Ferrari, RA Koup, BS Graham, BF Haynes, M Roederer, GD Tomaras Retrovirology 2009, 6(Suppl 3):O1 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania

RN Koehler, AM Walsh, E Saathoff, JR Currier, CT Bautista, N Moqueet, S Ratto-Kim, L Maboko, M Hoelscher, ML Robb, NL Michael, FE McCutchan, JH Kim, GH Kijak Retrovirology 2009, 6(Suppl 3):O2 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles

R Zuniga, B Mothe, A Llano, J Ibarrondo, M Daniels, M Farfan, J Suarez, JJ Szinger, W Hildebrand, A Lucchetti, D Heckerman, P Goulder, BD Walker, J Sanchez, BT Korber, C Brander Retrovirology 2009, 6(Suppl 3):O3 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects

S Munshaw, H Liao, A Dixon, X Chen, A Nagel, K Derosa, R Parks, J Amos, JF Whitesides, DJ Marshalls, Y Yang, F Gao, GD Tomaras, MA Moody, GH Kelsoe, TC Shea, DM Margolis, M Markowitz, P Goepfert, G Shaw, BF Haynes, TB Kepler Retrovirology 2009, 6(Suppl 3):O4 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

L Song, ZJ Sun, KE Coleman, MB Zwick, JS Gach, J Wang, EL Reinherz, G Wagner, M Kim Retrovirology 2009, 6(Suppl 3):O5 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target

SK Phogat, L Walker, D Wagner, P Chan-Hui, M Simek, P Phung, T Wrin, J Mitcham, P Investigator, S Kaminsky, T Zamb, M Moyle, W Koff, D Burton Retrovirology 2009, 6(Suppl 3):O6 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA011-01. Early events of human immunodeficiency virus type 1 (HIV-1) ex vivo penetration in the foreskin mimicking HIV-1 sexual transmission

Y Ganor, Z Zhou, A Schmitt, M Vacher-Lavenu, L Gibault, N Thiounn, J Tomasini, J Wolf, M Bomsel Retrovirology 2009, 6(Suppl 3):O7 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA011-02. Defining the mechanisms of HIV entry and interactions with the female genital tract

AM Carias, S McCoombe, M McRaven, M Anderson, R Veazey, TJ Hope Retrovirology 2009, 6(Suppl 3):O8 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA011-03. Clusterin, a natural ligand of DC-SIGN present in human semen inhibits HIV capture and transmission by dendritic cells

J Sabatte, W Faigle, A Ceballos, W Morelle, C Rodríguez, F Lenicov, M Thépaut, F Fieschi, H Lortat-Jacob, J Michalski, F Arenzana-Seisdedos, J Geffner, S Amigorena Retrovirology 2009, 6(Suppl 3):O9 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA011-04. Striking elevations in systemic and mucosal cytokine and chemokine levels in acute HIV-1 infection

A Stacey, P Norris, O Dibben, L Qin, M Cohen, C Gay, T Denny, P Borrow Retrovirology 2009, 6(Suppl 3):O10 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA011-05. TLR-mediated pDC responses to HIV-1 ligands

J Chang, S Kulkarni, A Meier, RJ Lindsay, S Bazner, JD Lifson, RJ Bosch, M Carrington, M Altfeld Retrovirology 2009, 6(Suppl 3):O11 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission

JR Lingappa, JP Hughes, D Donnel, JM Baeten, JI Mullins, MS Campbell, GE Gray, M Essex, C Farquhar, H Rees, A Wald, L Corey, C Celum Retrovirology 2009, 6(Suppl 3):O12 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

B Jacobs, K Kibler, S Wong, T Huynh, S Holechek, K Denzler, W Arndt, M Parrington, J Tartaglia, G Pantaleo Retrovirology 2009, 6(Suppl 3):O13 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV

F Tangy, M Février, M Guerbois, C Combredet, V Najburg, C Ruffié, A Morris, O Schwartz, R Legrand Retrovirology 2009, 6(Suppl 3):O14 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env

AK Wheatley, MR Alexander, JG Toe, RJ Center, DF Purcell Retrovirology 2009, 6(Suppl 3):O15 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies

X Shen, M Dennison, F Gao, DC Montefiori, L Verkoczy, B Haynes, M Alam, G Tomaras Retrovirology 2009, 6(Suppl 3):O16 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA021-05. Insertion of the HIV-1 gp41 epitopes 2F5 and 4E10 into the membrane-proximal region of the vesicular stomatitis virus glycoprotein

IC Lorenz, HT Nguyen, SK Phogat, SM Kaminsky, TJ Zamb, CL Parks Retrovirology 2009, 6(Suppl 3):O17 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro

J Cummings, V Arnold, K Yarbrough, C Didier, Y Levy, F Barré-Sinoussi, D Scott-Algara, HIV Vaccine Group Retrovirology 2009, 6(Suppl 3):O18 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA031-01. HIV-1 infection is characterized by early loss of CD161+ Th17 cells and gradual decline in regulatory T cells

A Prendergast, JG Prado, Y Kang, F Chen, LA Riddell, G Luzzi, P Goulder, P Klenerman Retrovirology 2009, 6(Suppl 3):O19 (22 October 2009)

Full text | PDF

Oral presentation   Open Access

OA031-02. Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway

M Nikolova, M Carriere, J Lelievre, M Muhtarova, A Bensussan, Y Lévy Retrovirology 2009, 6(Suppl 3):O20 (22 October 2009)

Full text | PDF

View more

  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.